FI71144C - Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat Download PDF

Info

Publication number
FI71144C
FI71144C FI820466A FI820466A FI71144C FI 71144 C FI71144 C FI 71144C FI 820466 A FI820466 A FI 820466A FI 820466 A FI820466 A FI 820466A FI 71144 C FI71144 C FI 71144C
Authority
FI
Finland
Prior art keywords
piperazinyl
fluoro
dihydro
oxo
naphthyridine
Prior art date
Application number
FI820466A
Other languages
English (en)
Finnish (fi)
Other versions
FI71144B (fi
FI820466L (fi
Inventor
Hitoshi Ichihashi
Terukazu Tanaka
Yu Imasato
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of FI820466L publication Critical patent/FI820466L/fi
Publication of FI71144B publication Critical patent/FI71144B/fi
Application granted granted Critical
Publication of FI71144C publication Critical patent/FI71144C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI820466A 1981-02-13 1982-02-12 Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat FI71144C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56020749A JPS57134482A (en) 1981-02-13 1981-02-13 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
JP2074981 1981-02-13

Publications (3)

Publication Number Publication Date
FI820466L FI820466L (fi) 1982-08-14
FI71144B FI71144B (fi) 1986-08-14
FI71144C true FI71144C (fi) 1986-11-24

Family

ID=12035831

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820466A FI71144C (fi) 1981-02-13 1982-02-12 Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat

Country Status (19)

Country Link
US (1) US4442101A (fr)
EP (1) EP0058614B1 (fr)
JP (1) JPS57134482A (fr)
KR (1) KR870000322B1 (fr)
AU (1) AU547082B2 (fr)
CA (1) CA1216292A (fr)
CS (1) CS254958B2 (fr)
DD (1) DD202573A5 (fr)
DE (1) DE3266261D1 (fr)
DK (1) DK160046C (fr)
ES (1) ES509538A0 (fr)
FI (1) FI71144C (fr)
HU (1) HU186473B (fr)
MX (1) MX158194A (fr)
NO (1) NO156721C (fr)
PH (1) PH18177A (fr)
PL (1) PL137259B1 (fr)
YU (1) YU43785B (fr)
ZA (1) ZA82740B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2758259A (en) * 1953-06-23 1956-08-07 Mallory & Co Inc P R Electrolytic capacitor device
US2856570A (en) * 1954-06-02 1958-10-14 Mallory & Co Inc P R Electrolytic capacitor
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US8629178B2 (en) * 2009-11-03 2014-01-14 Li Liu Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof
US20160046603A1 (en) * 2013-03-08 2016-02-18 Melinta Therapeutics, Inc. Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate
KR102214067B1 (ko) 2014-02-27 2021-02-09 엘지전자 주식회사 산 질화물 형광체, 그 제조 방법 및 이를 이용한 발광 소자 패키지

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
US3590036A (en) * 1968-11-18 1971-06-29 George Y Lesher Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof
CA947301A (en) * 1970-01-28 1974-05-14 Sumitomo Chemical Company Process for the preparation of compound having antibacterial action
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS57134482A (en) * 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation

Also Published As

Publication number Publication date
FI71144B (fi) 1986-08-14
EP0058614B1 (fr) 1985-09-18
HU186473B (en) 1985-08-28
KR870000322B1 (ko) 1987-02-27
JPS57134482A (en) 1982-08-19
DK63482A (da) 1982-08-14
NO820430L (no) 1982-08-16
YU26582A (en) 1986-04-30
YU43785B (en) 1989-12-31
DK160046C (da) 1991-06-10
CS99882A2 (en) 1987-07-16
PH18177A (en) 1985-04-12
PL137259B1 (en) 1986-05-31
ZA82740B (en) 1982-12-29
US4442101A (en) 1984-04-10
AU547082B2 (en) 1985-10-03
FI820466L (fi) 1982-08-14
CS254958B2 (en) 1988-02-15
AU8017382A (en) 1982-08-19
DK160046B (da) 1991-01-21
PL235049A1 (fr) 1982-09-27
JPH0243753B2 (fr) 1990-10-01
ES8307793A1 (es) 1983-08-01
MX158194A (es) 1989-01-16
NO156721B (no) 1987-08-03
EP0058614A1 (fr) 1982-08-25
ES509538A0 (es) 1983-08-01
DE3266261D1 (en) 1985-10-24
DD202573A5 (de) 1983-09-21
NO156721C (no) 1987-11-11
KR830009096A (ko) 1983-12-17
CA1216292A (fr) 1987-01-06

Similar Documents

Publication Publication Date Title
FI71144C (fi) Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat
AU2003254376B2 (en) 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino) -1-phenyl- methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
US4337257A (en) Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, their preparation, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
DE3144455C2 (fr)
CZ398191A3 (en) Novel 4-amino alkyl-2(3h)-indolones and pharmaceutical compositions containing them
JPS62277362A (ja) 新規キノロン誘導体、そのエステルおよびその塩
EP0046666B1 (fr) 2(3H)-Indolones, procédé de préparation et compositions les contenant
CA1225091A (fr) Derives de substitution de l'acide benzoquinolizine- carboxylique; preparation
JPS60126284A (ja) ピリドンカルボン酸誘導体およびその塩
FI62311B (fi) Foerfarande foer framstaellning av kristallint natrium- och kaiumcefalexinmonohydrat
GB2044254A (en) Novel piperidine derivatives
JPH0212229B2 (fr)
JPS61100569A (ja) 新規化合物,その製造及びそれを含有する医薬組成物
Price et al. Some 4-Amino-7-chloroquinoline Derivatives1
CZ299700B6 (cs) Krystalová modifikace C kyseliny 8-kyano-1-cyklopropyl-7-(1S, 6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, zpusob její výroby a její použití
KR100372964B1 (ko) 피페리딘유도체결정,이의제조용중간생성물및이의제조방법
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
JPS58148883A (ja) ピリドベンゾジアゼピノン化合物
US4256753A (en) 4-(2-Pyridylamino)phenylacetic acid derivatives
JPH07508495A (ja) オキシテトラサイクリンの精製方法および中間体
Poliakoff et al. Synthetic trypanocides. 3. Structure-activity relations
GB2100261A (en) Aminophenylalkylamine derivatives, a process for their preparation and their use as pharmaceuticals
US6075035A (en) Crystal of hydrate and process for preparation thereof
KR100503158B1 (ko) 안트라닐산디아미드유도체,이의제조방법및항가스트린제로서의이의약제학적용도
US3287456A (en) Bismuth iodide complex of salts of racemic 2-dehydroemetine

Legal Events

Date Code Title Description
MA Patent expired

Owner name: DAINIPPON PHARMACEUTICAL CO.,_LTD.